1
|
Abstract
OBJECTIVE Lack of access to mental health treatment remains a significant problem in the United States, even after implementation of mental health parity legislation. This study examined availability of psychiatrists listed in insurance carrier network provider databases in the Washington, D.C., area. METHODS Contact information was obtained for 1,184 psychiatrists listed in online directories for three of the largest insurance carriers serving the Washington, D.C., area. The "mystery shopper" method was used to assess the accuracy of listed contact information, new outpatient appointment availability, and average wait times for 50 psychiatrists randomly selected from each insurance directory. RESULTS Most (77%) physicians were successfully contacted, meaning that someone answered the phone or returned a voice mail message, and 51% of the psychiatrists had working telephone numbers verified to be correct. Fifteen percent of the psychiatrists were accepting new outpatients with the target insurance, with average wait times of 19 days; only 7% were able to schedule an appointment within two weeks. CONCLUSIONS Inaccuracy of insurance provider directories significantly affected the ability of patients to obtain timely mental care.
Collapse
Affiliation(s)
- Benzion Blech
- Dr. Blech is with the Department of Neurology, Mayo Clinic, Phoenix. The other authors are with the American Psychiatric Association, Arlington, Virginia, where Dr. West and Ms. Barber are with the APA Foundation, Ms. Yang and Ms. Coyle are with the Office of General Counsel, and Dr. Wang is with the Division of Research
| | - Joyce C West
- Dr. Blech is with the Department of Neurology, Mayo Clinic, Phoenix. The other authors are with the American Psychiatric Association, Arlington, Virginia, where Dr. West and Ms. Barber are with the APA Foundation, Ms. Yang and Ms. Coyle are with the Office of General Counsel, and Dr. Wang is with the Division of Research
| | - Zhuoyin Yang
- Dr. Blech is with the Department of Neurology, Mayo Clinic, Phoenix. The other authors are with the American Psychiatric Association, Arlington, Virginia, where Dr. West and Ms. Barber are with the APA Foundation, Ms. Yang and Ms. Coyle are with the Office of General Counsel, and Dr. Wang is with the Division of Research
| | - Keila D Barber
- Dr. Blech is with the Department of Neurology, Mayo Clinic, Phoenix. The other authors are with the American Psychiatric Association, Arlington, Virginia, where Dr. West and Ms. Barber are with the APA Foundation, Ms. Yang and Ms. Coyle are with the Office of General Counsel, and Dr. Wang is with the Division of Research
| | - Philip Wang
- Dr. Blech is with the Department of Neurology, Mayo Clinic, Phoenix. The other authors are with the American Psychiatric Association, Arlington, Virginia, where Dr. West and Ms. Barber are with the APA Foundation, Ms. Yang and Ms. Coyle are with the Office of General Counsel, and Dr. Wang is with the Division of Research
| | - Colleen Coyle
- Dr. Blech is with the Department of Neurology, Mayo Clinic, Phoenix. The other authors are with the American Psychiatric Association, Arlington, Virginia, where Dr. West and Ms. Barber are with the APA Foundation, Ms. Yang and Ms. Coyle are with the Office of General Counsel, and Dr. Wang is with the Division of Research
| |
Collapse
|
2
|
West JC, Clarke DE, Duffy FF, Barber KD, Mościcki EK, Mojtabai R, Ptakowski KK, Levin S. Are Psychiatrists Ready for Health Care Reform? Findings From the Study of Psychiatric Practice Under Health Care Reform. Psychiatr Serv 2016; 67:1292-1299. [PMID: 27524368 DOI: 10.1176/appi.ps.201500536] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE This study sought to describe the extent to which psychiatrists, prior to insurance expansions under the Affordable Care Act (ACA), reported currently participating or being likely to participate in integrated services delivery models, to assume new roles, to accept new reimbursement structures, and to use electronic health records (EHRs). METHODS A cross-sectional probability survey of U.S. psychiatrists was fielded from September to December 2013. In total, 2,800 psychiatrists were randomly selected from the AMA Physician Masterfile, and 45% responded. Of these, 93% (N=1,099) reported treating patients, forming the sample. RESULTS Overall, 29% reported practicing in new ACA or integrated models, and 64% reported assuming at least one new role. Forty-two percent reported currently receiving a salary; other capitated and risk-based reimbursement was rarely used. Half (53%) reported current use of EHRs for clinical functions not limited to billing or practice management; only 21% reported participating in the Medicare or Medicaid EHR Incentive Program. Those who reported currently practicing or being very likely to practice in primary care or integrated treatment settings, to assume at least one ACA role, to receive a salary, or to use an EHR were younger and more racially-ethnically diverse and more likely to see Medicaid and public outpatient clinic patients Conclusions: Although substantial proportions of psychiatrists reported current practice in ACA services delivery models and ACA roles, the findings highlight opportunities for workforce development, training, and technical assistance to strengthen participation in these activities. The findings also underscore the need to prepare psychiatrists for merit-based payment reforms and use of EHRs.
Collapse
Affiliation(s)
- Joyce C West
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Diana E Clarke
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Farifteh Firoozmand Duffy
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Keila D Barber
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Eve K Mościcki
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Ramin Mojtabai
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Kristin Kroeger Ptakowski
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Saul Levin
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| |
Collapse
|
3
|
West JC, Clarke DE, Duffy FF, Barber KD, Mojtabai R, Mościcki EK, Kroeger Ptakowski K, Levin S. Availability of Mental Health Services Prior to Health Care Reform Insurance Expansions. Psychiatr Serv 2016; 67:983-9. [PMID: 27079993 DOI: 10.1176/appi.ps.201500423] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVES This study sought to examine psychiatrists' perceptions of gaps in the availability of mental health and substance use services and their ability to spend sufficient time and provide enough visits to meet patients' clinical needs. METHODS A cross-sectional probability survey of U.S. psychiatrists was fielded during September through December 2013 by using practice-based research methods, including distribution by priority mail. Psychiatrists (N=2,800) were randomly selected from the American Medical Association Physician Masterfile, and 1,188 of the 2,615 (45%) with deliverable addresses responded. Of those, 93% (N=1,099) reported currently treating psychiatric patients, forming the sample for this study. RESULTS Thirty percent or more of psychiatrists reported being unable to provide or find a source for each of the following services in the past 30 days: psychotherapy, housing, supported employment, case management or assertive community treatment, and substance use treatment. Approximately 20% reported being unable to provide or find a source for inpatient treatment, psychosocial rehabilitation, general medical care, pharmacologic treatment, and child and adolescent treatment. Approximately half (52%) of psychiatrists reported not having enough time during patient visits, affecting 28% of patients. More than one-third (37%) reported being unable to provide enough visits to meet patients' clinical needs, affecting 24% of patients. CONCLUSIONS Psychiatrists reported constrained availability of a range of mental health, substance use, and general medical services. In order for the Affordable Care Act to realize the promise of increased access to care, the infrastructure for mental health and substance use treatment, workforce, and services delivery may require significant enhancement.
Collapse
Affiliation(s)
- Joyce C West
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Diana E Clarke
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Farifteh Firoozmand Duffy
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Keila D Barber
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Ramin Mojtabai
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Eve K Mościcki
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Kristin Kroeger Ptakowski
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| | - Saul Levin
- Dr. West, Dr. Clarke, Dr. Duffy, Ms. Barber, and Dr. Mościcki are with the American Psychiatric Association Foundation, Arlington, Virginia (e-mail: ). Dr. Clarke is also with the Division of Research, American Psychiatric Association, Arlington, Virginia. Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore. Ms. Kroeger Ptakowski and Dr. Levin are with the American Psychiatric Association, Arlington, Virginia
| |
Collapse
|
4
|
Wilk JE, Herrell RK, Carr AL, West JC, Wise J, Hoge CW. Diagnosis of PTSD by Army Behavioral Health Clinicians: Are Diagnoses Recorded in Electronic Health Records? Psychiatr Serv 2016; 67:878-82. [PMID: 26975516 DOI: 10.1176/appi.ps.201500292] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE The study sought to identify the extent to which posttraumatic stress disorder (PTSD) diagnoses are recorded in the electronic health record (EHR) in Army behavioral health clinics and to assess clinicians' reasons for not recording them and treatment factors associated with recording or not recording the diagnosis. METHODS A total of 543 Army mental health providers completed the anonymous, Web-based survey. Clinicians reported clinical data for 399 service member patients, of whom 110 (28%) had a reported PTSD diagnosis. Data were weighted to account for sampling design and nonresponses. RESULTS Of those given a diagnosis of PTSD by their clinician, 59% were reported to have the diagnosis recorded in the EHR, and 41% did not. The most common reason for not recording was reducing stigma or protecting the service member's career prospects. Psychiatrists were more likely than psychologists or social workers to record the diagnosis. CONCLUSIONS Findings indicate that for many patients presenting with PTSD in Army behavioral health clinics at the time of the survey (2010), clinicians did not record a PTSD diagnosis in the EHR, often in an effort to reduce stigma. This pattern may exist for other diagnoses. Recent Army policy has provided guidance to clinicians on diagnostic recording practice. An important implication concerns the reliance on coded diagnoses in PTSD surveillance efforts by the U.S. Department of Defense (DoD). The problem of underestimated prevalence rates may be further compounded by overly narrow DoD surveillance definitions of PTSD.
Collapse
Affiliation(s)
- Joshua E Wilk
- Except for Dr. West, the authors are with the Center for Military Psychiatry and Neurosciences, Walter Reed Army Institute of Research, Silver Spring, Maryland (e-mail: ). Dr. West is with the Psychiatric Research Network, American Psychiatric Institute for Research and Education, American Psychiatric Association, Arlington, Virginia
| | - Richard K Herrell
- Except for Dr. West, the authors are with the Center for Military Psychiatry and Neurosciences, Walter Reed Army Institute of Research, Silver Spring, Maryland (e-mail: ). Dr. West is with the Psychiatric Research Network, American Psychiatric Institute for Research and Education, American Psychiatric Association, Arlington, Virginia
| | - Abby L Carr
- Except for Dr. West, the authors are with the Center for Military Psychiatry and Neurosciences, Walter Reed Army Institute of Research, Silver Spring, Maryland (e-mail: ). Dr. West is with the Psychiatric Research Network, American Psychiatric Institute for Research and Education, American Psychiatric Association, Arlington, Virginia
| | - Joyce C West
- Except for Dr. West, the authors are with the Center for Military Psychiatry and Neurosciences, Walter Reed Army Institute of Research, Silver Spring, Maryland (e-mail: ). Dr. West is with the Psychiatric Research Network, American Psychiatric Institute for Research and Education, American Psychiatric Association, Arlington, Virginia
| | - Joseph Wise
- Except for Dr. West, the authors are with the Center for Military Psychiatry and Neurosciences, Walter Reed Army Institute of Research, Silver Spring, Maryland (e-mail: ). Dr. West is with the Psychiatric Research Network, American Psychiatric Institute for Research and Education, American Psychiatric Association, Arlington, Virginia
| | - Charles W Hoge
- Except for Dr. West, the authors are with the Center for Military Psychiatry and Neurosciences, Walter Reed Army Institute of Research, Silver Spring, Maryland (e-mail: ). Dr. West is with the Psychiatric Research Network, American Psychiatric Institute for Research and Education, American Psychiatric Association, Arlington, Virginia
| |
Collapse
|
5
|
Abstract
OBJECTIVE Professional burnout is a well-documented occupational phenomenon, characterized by the gradual "wearing away" of an individual's physical and mental well-being, resulting in a variety of adverse job-related outcomes. It has been suggested that burnout is more common in occupations that require close interpersonal relationships, such as mental health services. METHODS This study surveyed 488 mental health clinicians working with military populations about work-related outcomes, including level of professional burnout, job satisfaction, and other work-related domains. RESULTS Approximately 21% (weighted) of the sample reported elevated levels of burnout; several domains were found to be significantly associated with burnout. CONCLUSIONS Education about professional burnout symptoms and early intervention are essential to ensure that providers continue to provide optimal care for service members and veterans.
Collapse
Affiliation(s)
- Brian C Kok
- Mr. Kok, Dr. Herrell, Ms. Grossman, and Dr. Wilk are with the Department of Military Psychiatry, Walter Reed Army Institute of Research, Silver Spring, Maryland (e-mail: ). Dr. West is with the Psychiatric Research Network, American Psychiatric Institute for Research and Education, Arlington, Virginia
| | - Richard K Herrell
- Mr. Kok, Dr. Herrell, Ms. Grossman, and Dr. Wilk are with the Department of Military Psychiatry, Walter Reed Army Institute of Research, Silver Spring, Maryland (e-mail: ). Dr. West is with the Psychiatric Research Network, American Psychiatric Institute for Research and Education, Arlington, Virginia
| | - Sasha H Grossman
- Mr. Kok, Dr. Herrell, Ms. Grossman, and Dr. Wilk are with the Department of Military Psychiatry, Walter Reed Army Institute of Research, Silver Spring, Maryland (e-mail: ). Dr. West is with the Psychiatric Research Network, American Psychiatric Institute for Research and Education, Arlington, Virginia
| | - Joyce C West
- Mr. Kok, Dr. Herrell, Ms. Grossman, and Dr. Wilk are with the Department of Military Psychiatry, Walter Reed Army Institute of Research, Silver Spring, Maryland (e-mail: ). Dr. West is with the Psychiatric Research Network, American Psychiatric Institute for Research and Education, Arlington, Virginia
| | - Joshua E Wilk
- Mr. Kok, Dr. Herrell, Ms. Grossman, and Dr. Wilk are with the Department of Military Psychiatry, Walter Reed Army Institute of Research, Silver Spring, Maryland (e-mail: ). Dr. West is with the Psychiatric Research Network, American Psychiatric Institute for Research and Education, Arlington, Virginia
| |
Collapse
|
6
|
West JC, Rae DS, Mojtabai R, Duffy FF, Kuramoto J, Moscicki E, Narrow WE. Planning Patient-Centered Health Homes for Medicaid Psychiatric Patients at Greatest Risk for Intensive Service Use. Community Ment Health J 2015; 51:513-22. [PMID: 25666205 DOI: 10.1007/s10597-015-9834-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2013] [Accepted: 01/23/2015] [Indexed: 10/24/2022]
Abstract
This study identified characteristics of Medicaid psychiatric patients at risk of hospitalizations and emergency department (ED) visits to identify their service delivery needs. A total of 4,866 psychiatrists were randomly selected from the AMA Physician Masterfile; 62 % responded, 32 % met eligibility criteria and reported on 1,625 Medicaid patients. Patients with schizophrenia, substance use disorders, suicidal and violent ideation/behavior, and psychotic, substance use, or manic symptoms were at high risk for intensive service use, along with homeless and incarcerated patients. Patients with schizophrenia or psychotic symptoms represented 37 % of patients, but used 73 % of all hospital days and 61 % of all ED visits. Patients with substance use problems comprised 21 % of patients, but used nearly half of all ED visits. Our findings highlight opportunities to enhance treatments and interventions, and inform the development of patient-centered health homes to address the needs of patients at high risk for intensive service use.
Collapse
Affiliation(s)
- Joyce C West
- American Psychiatric Foundation, 1000 Wilson Blvd, Suite 1825, Arlington, VA, 22209, USA,
| | | | | | | | | | | | | |
Collapse
|
7
|
West JC, Mościcki EK, Duffy FF, Wilk JE, Countis L, Narrow WE, Regier DA. APIRE Practice Research Network: accomplishments, challenges, and lessons learned. Psychother Res 2014; 25:152-65. [PMID: 24386950 DOI: 10.1080/10503307.2013.868948] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
Abstract
The Practice Research Network (PRN) was established in 1993 to bridge the gap between the science base and the clinical practice of psychiatry by expanding the generalizability of findings and involving clinicians in the development and conduct of research. It began as a nationwide network of psychiatrists and has evolved to conduct large-scale, clinical and policy research studies using randomly selected samples of psychiatrists from the AMA Physician Masterfile. This paper provides an overview of major PRN initiatives and the impact of these studies. It describes the benefits to clinicians of participating in PRN research, as well as strategies developed to address key challenges.
Collapse
Affiliation(s)
- Joyce C West
- a American Psychiatric Institute for Research and Education , Arlington , VA , USA
| | | | | | | | | | | | | |
Collapse
|
8
|
Duffy FF, Fochtmann LJ, Craig T, West JC, Mościcki EK. Performance in Practice: Clinical Module for the Care of Patients With Posttraumatic Stress Disorder. FOC 2013. [DOI: 10.1176/appi.focus.11.3.341] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
9
|
Abstract
OBJECTIVE To identify the extent to which evidence-based psychotherapy (EBP) and psychopharmacologic treatments for posttraumatic stress disorder (PTSD) are provided to U.S. service members in routine practice, and the degree to which they are consistent with evidence-based treatment guidelines. METHOD We surveyed the majority of Army behavioral health providers (n = 2,310); surveys were obtained from 543 (26%). These clinicians reported clinical data on a total sample of 399 service member patients. Of these patients, 110 (28%) had a reported PTSD diagnosis. Data were weighted to account for sampling design and nonresponses. RESULTS Army providers reported 86% of patients with PTSD received evidence-based psychotherapy (EBP) for PTSD. As formal training hours in EBPs increased, reported use of EBPs significantly increased. Although EBPs for PTSD were reported to be widely used, clinicians who deliver EBP frequently reported not adhering to all core procedures recommended in treatment manuals; less than half reported using all the manualized core EBP techniques. CONCLUSIONS Further research is necessary to understand why clinicians modify EBP treatments, and what impact this has on treatment outcomes. More data regarding the implications for treatment effectiveness and the role of clinical context, patient preferences, and clinical decision-making in adapting EBPs could help inform training efforts and the ways that these treatments may be better adapted for the military.
Collapse
|
10
|
West JC, Rae DS, Mojtabai R, Rubio-Stipec M, Kreyenbuhl JA, Alter CL, Crystal S. Clinically unintended medication switches and inability to prescribe preferred medications under Medicare Part D. J Psychopharmacol 2012; 26:784-93. [PMID: 21693550 DOI: 10.1177/0269881111406304] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Medicare Part D has expanded medication access; however, there is some evidence that dually eligible psychiatric patients have experienced medication access problems. The aim of this study was to characterize medication switches and access problems for dually eligible psychiatric patients and associations with adverse events, including emergency department visits, hospitalizations, homelessness, and incarceration. Reports on 986 systematically sampled, dually eligible patients were obtained from a random sample of practicing psychiatrists. A total of 27.6% of previously stable patients had to switch medications because clinically indicated and preferred refills were not covered or approved. An additional 14.0% were unable to have clinically indicated/preferred medications prescribed because of drug coverage/approval. Adjusting for case-mix, switched patients (p = 0.0009) and patients with problems obtaining clinically indicated medications (p = 0.0004) had significantly higher adverse event rates. Patients at greatest risk were prescribed a medication in a different class or could not be prescribed clinically-indicated atypical antipsychotics, other antidepressants, mood stabilizers, or stimulants. Patients with problems obtaining clinically preferred/indicated antipsychotics had a 17.6 times increased odds (p = 0.0039) of adverse events. These findings call for caution in medication switches for stable patients and support prescription drug policies promoting access to clinically indicated medications and continuity for clinically stable patients.
Collapse
Affiliation(s)
- Joyce C West
- American Psychiatric Institute for Research and Education, Arlington, VA 22209, USA.
| | | | | | | | | | | | | |
Collapse
|
11
|
Compton MT, Simmons CM, Weiss PS, West JC. Axis IV psychosocial problems among patients with psychotic or mood disorders with a cannabis use disorder comorbidity. Am J Addict 2011; 20:563-7. [PMID: 21999503 DOI: 10.1111/j.1521-0391.2011.00184.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Among 1,610 patients with psychotic or mood disorders in routine psychiatric practice, odds ratios (crude and adjusted for age, education, gender, and race) quantified associations between the presence of comorbid cannabis abuse/dependence and seven psychosocial problems. Results revealed a higher prevalence of five of seven Axis IV psychosocial problems among patients who had a psychotic or mood disorder and a comorbid cannabis use disorder. The results underscore the need for careful screening and treatment of comorbid cannabis abuse/dependence among patients with psychotic or mood disorders given the prominent associated psychosocial impairments in this population.
Collapse
Affiliation(s)
- Michael T Compton
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
| | | | | | | |
Collapse
|
12
|
Kaufmann CN, Spira AP, Rae DS, West JC, Mojtabai R. Sleep problems, psychiatric hospitalization, and emergency department use among psychiatric patients with Medicaid. Psychiatr Serv 2011; 62:1101-5. [PMID: 21885593 PMCID: PMC3170089 DOI: 10.1176/appi.ps.62.9.1101] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE This study examined the prevalence of sleep problems and their association with the use of inpatient and emergency department services by Medicaid recipients with serious mental illness. METHODS The sample consisted of 1,560 psychiatric patients with Medicaid coverage who were identified in a ten-state random survey of psychiatrists. Sleep problems were assessed by clinician ratings. RESULTS Over 75% of the patients experienced a sleep problem, and approximately 50% of these patients had problems that were moderate to severe. Greater sleep problem severity was associated with an increased risk of psychiatric hospitalization and emergency department visits for mental health reasons. CONCLUSIONS Sleep problems were highly prevalent among Medicaid patients with serious mental illness and were associated with greater inpatient and emergency mental health service use. More careful monitoring and management of sleep problems in this patient population could address a common clinical need and might help to reduce costly service use.
Collapse
Affiliation(s)
- Christopher N Kaufmann
- Johns Hopkins Bloomberg School of Public Health–Mental Health, Hampton House, 624 North Broadway, 8th Floor, Baltimore, MD 21205, USA.
| | | | | | | | | |
Collapse
|
13
|
Duffy FF, West JC, Fochtmann LJ, Willenbring ML, Plovnick R, Kunkle R, Eld B. Performance in Practice: Physician Practice Assessment Tools for the Screening, Assessment, and Treatment of Adults with Substance Use Disorder. FOC 2011. [DOI: 10.1176/foc.9.1.foc31] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
14
|
Mościcki EK, West JC, Rae DS, Rubio-Stipec M, Wilk JE, Regier DA. Suicidality is associated with medication access problems in publicly insured psychiatric patients. J Clin Psychiatry 2010; 71:1657-63. [PMID: 21190639 DOI: 10.4088/jcp.10m06177gre] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2010] [Accepted: 09/13/2010] [Indexed: 10/18/2022]
Abstract
BACKGROUND Beginning January 1, 2006, the Medicare Part D prescription drug benefit shifted drug coverage from Medicaid to the new Medicare Part D program for patients who were eligible for both Medicare and Medicaid benefits ("dual-eligibles"). These patients were randomly assigned to a private Part D plan and came under specific formulary and utilization management procedures of the plan in which they were enrolled. OBJECTIVE To examine the relationship between physician-reported medication switches, discontinuations, and other access problems and suicidal ideation or behavior among "dual-eligible" psychiatric patients. METHOD Data were collected in 3 cross-sectional cycles in 2006 (January-April, May-August, and September-December) as part of the National Study of Medicaid and Medicare Psychopharmacologic Treatment Access and Continuity using through-the-mail, practice-based survey research methods. Data from the third cycle, representing all events since January 1, 2006, were used for these analyses. A national sample of psychiatrists randomly selected from the AMA Masterfile provided clinically detailed data on 1 systematically selected, dual-eligible psychiatric patient (N = 908). Propensity score analyses adjusted for patient sociodemographics, treatment setting, diagnoses, and psychiatric symptom severity. RESULTS Patients who experienced medication switches, discontinuations, and other access problems had 3 times the rate of suicidal ideation or behavior compared with patients with no access problems (22.0% vs 7.4%, P < .0001). Mean odds ratios and excess probabilities were highest for patients who were clinically stable but were required to switch medications (31.8%; mean OR = 4.87, mean P = 8.92(-5), excess probability = 0.21). Patients who experienced discontinuations (26.4%; mean OR = 2.13, mean P = 2.12(-2), excess probability = 0.12), other access problems (18.7%; mean OR = 3.01, mean P = 1.03(-5), excess probability = 0.15), and multiple access problems (22.3%; mean OR = 2.88, mean P = 4.10(-5), excess probability = 0.14) also had significantly increased suicidal ideation or behavior. CONCLUSION Increased occurrences of suicidal ideation or behavior appear to be associated with disruptions in patient medication access and continuity. Clinicians need to be aware of the possibility of increased suicidality when, for administrative reasons, a clinically stable patient's medication regimen is altered. Dual-eligible psychiatric patients represent a highly vulnerable group with a substantial burden of illness; these findings underscore the need to provide special protections for this population.
Collapse
Affiliation(s)
- Eve K Mościcki
- American Psychiatric Institute for Research and Education, Arlington, Virginia, USA.
| | | | | | | | | | | |
Collapse
|
15
|
West JC, Rae DS, Huskamp HA, Rubio-Stipec M, Regier DA. Medicaid medication access problems and increased psychiatric hospital and emergency care. Gen Hosp Psychiatry 2010; 32:615-22. [PMID: 21112454 DOI: 10.1016/j.genhosppsych.2010.07.005] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/10/2010] [Revised: 07/15/2010] [Accepted: 07/16/2010] [Indexed: 01/19/2023]
Abstract
OBJECTIVES To quantify the extent to which Medicaid programs may incur increased psychiatric emergency department and hospital use associated with clinically unintended medication discontinuations, gaps, switches and other access problems attributed to prescription drug coverage and management. METHOD This study uses clinically detailed, physician-reported data. A total of 4866 psychiatrists in 10 states were randomly selected from the AMA Masterfile; 62% responded and 32% treated Medicaid patients and reported on 1625 systematically selected Medicaid patients. Propensity score multivariate models assessed predicted probabilities and mean number of emergency department visits and hospital days. RESULTS Many patients (46.0%, S.E.=1.3%) had medication access problems reported during the past year, including discontinuing or switching medications or inability to obtain clinically indicated prescriptions because of drug coverage or management. The expected number of emergency department visits was estimated to be 73.8% higher among patients with medication access problems reported compared to matched patients without access problems reported. Among acute stay inpatients, the expected number of hospital days was 71.7% higher for patients with medication access problems reported. CONCLUSIONS Medication access problems may have significant implications for Medicaid programs. The potential indirect costs of these policies in psychiatric and social services utilization should be considered in addition to direct pharmacy costs.
Collapse
Affiliation(s)
- Joyce C West
- American Psychiatric Institute for Research and Education, Arlington, VA 22209, USA.
| | | | | | | | | |
Collapse
|
16
|
West JC, Wilk JE, Rae DS, Muszynski IL, Rubio-Stipec M, Alter CL, Sanders KE, Crystal S, Regier DA. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients. J Clin Psychiatry 2010; 71:400-10. [PMID: 19925748 DOI: 10.4088/jcp.08m04608whi] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2008] [Accepted: 01/02/2009] [Indexed: 10/20/2022]
Abstract
OBJECTIVE This study provides national data on medication access and continuity problems experienced during the first year of the Medicare Part D prescription drug program, which was implemented on January 1, 2006, among a national sample of Medicare and Medicaid "dual eligible" psychiatric patients. METHOD Practice-based research methods were used to collect clinician-reported data across the full range of public and private psychiatric treatment settings. A random sample of psychiatrists was selected from the American Medical Association Physician Masterfile. Among these physicians, 1,490 provided clinically detailed data on a systematically selected sample of 2,941 dual eligible psychiatric patients. RESULTS Overall, 43.3% of patients were reported to be unable to obtain clinically indicated medication refills or new prescriptions in 2006 because they were not covered or approved; 28.9% discontinued or temporarily stopped their medication(s) as a result of prescription drug coverage or management issues; and 27.7% were reported to be previously stable on their medications but were required to switch medications. Adjusting for case mix to control for sociodemographic and clinical confounders, the predicted probability of an adverse event among patients with medication access problems was 0.64 compared to 0.36 for those without access problems (P < .0001). All prescription drug utilization management features studied were associated with increased medication access problems (P < .0001). Adjusting for patient case mix, patients with "step therapy" (P < .0001), limits on medication number/dosing (P < .0001), or prior authorization (P < .0001) had 2.4 to 3.4 times the increased likelihood of an adverse event. CONCLUSIONS More effective Part D policies and management practices are needed to promote clinically safer and appropriate pharmacotherapy for psychiatric patients to enhance treatment outcomes.
Collapse
Affiliation(s)
- Joyce C West
- American Psychiatric Institute for Research and Education Practice Research Network, 1000 Wilson Blvd, Suite 1825, Arlington, VA 22209, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Huskamp HA, West JC, Rae DS, Rubio-Stipec M, Regier DA, Frank RG. Part D and dually eligible patients with mental illness: medication access problems and use of intensive services. Psychiatr Serv 2010. [PMID: 19723730 DOI: 10.1176/appi.ps.60.9.1169] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE This study examined the occurrence of medication access problems and use of intensive mental health services after the transition in January 2006 from Medicaid drug coverage to Medicare Part D for persons dually eligible for Medicaid and Medicare benefits. METHODS Psychiatrists randomly selected from the American Medical Association's Physicians Masterfile reported on experiences of one systematically selected dually eligible patient (N=908) in the nine to 12 months after Part D implementation. Propensity score matching was used to compare use of psychiatric emergency department care and inpatient care between individuals who experienced a problem accessing a psychiatric medication after Part D and those who did not. RESULTS Approximately 44% of dually eligible patients were reported to have experienced a problem accessing medications. The likelihood of visiting an emergency department was significantly higher for those who experienced an access problem than for those who did not (mean odds ratio=1.75, mean p=.003). There was no difference in number of emergency department visits or hospitalizations for those who had at least one. CONCLUSIONS Many dually eligible patients had difficulty accessing psychiatric medications after implementation of Part D. These patients were significantly more likely to visit psychiatric emergency departments than patients who did not experience difficulties. These findings raise concerns about possible negative effects on quality of care. Additional study is needed to understand the full effects of Part D on outcomes and functioning as well as treatment costs for this population.
Collapse
Affiliation(s)
- Haiden A Huskamp
- Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave., Boston, MA 02115, USA.
| | | | | | | | | | | |
Collapse
|
18
|
Huskamp HA, West JC, Rae DS, Rubio-Stipec M, Regier DA, Frank RG. Part D and dually eligible patients with mental illness: medication access problems and use of intensive services. Psychiatr Serv 2009; 60:1169-74. [PMID: 19723730 PMCID: PMC2768558 DOI: 10.1176/ps.2009.60.9.1169] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE This study examined the occurrence of medication access problems and use of intensive mental health services after the transition in January 2006 from Medicaid drug coverage to Medicare Part D for persons dually eligible for Medicaid and Medicare benefits. METHODS Psychiatrists randomly selected from the American Medical Association's Physicians Masterfile reported on experiences of one systematically selected dually eligible patient (N=908) in the nine to 12 months after Part D implementation. Propensity score matching was used to compare use of psychiatric emergency department care and inpatient care between individuals who experienced a problem accessing a psychiatric medication after Part D and those who did not. RESULTS Approximately 44% of dually eligible patients were reported to have experienced a problem accessing medications. The likelihood of visiting an emergency department was significantly higher for those who experienced an access problem than for those who did not (mean odds ratio=1.75, mean p=.003). There was no difference in number of emergency department visits or hospitalizations for those who had at least one. CONCLUSIONS Many dually eligible patients had difficulty accessing psychiatric medications after implementation of Part D. These patients were significantly more likely to visit psychiatric emergency departments than patients who did not experience difficulties. These findings raise concerns about possible negative effects on quality of care. Additional study is needed to understand the full effects of Part D on outcomes and functioning as well as treatment costs for this population.
Collapse
Affiliation(s)
- Haiden A Huskamp
- Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave., Boston, MA 02115, USA.
| | | | | | | | | | | |
Collapse
|
19
|
West JC, Wilk JE, Rae DS, Muszynski IS, Stipec MR, Alter CL, Sanders KE, Crystal S, Regier DA. Medicaid prescription drug policies and medication access and continuity: findings from ten states. Psychiatr Serv 2009; 60:601-10. [PMID: 19411346 DOI: 10.1176/ps.2009.60.5.601] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVES The aims of this study were to compare medication access problems among psychiatric patients in ten state Medicaid programs, assess adverse events associated with medication access problems, and determine whether prescription drug utilization management is associated with access problems and adverse events. METHODS Psychiatrists from the American Medical Association's Masterfile were randomly selected (N=4,866). Sixty-two percent responded; 32% treated Medicaid patients and were randomly assigned a start day and time to report on two Medicaid patients (N=1,625 patients). RESULTS A medication access problem in the past year was reported for a mean+/-SE of 48.3%+/-2.0% of the patients, with a 37.6% absolute difference between states with the lowest and highest rates (p<.001). The most common access problems were not being able to access clinically indicated medication refills or new prescriptions because Medicaid would not cover or approve them (34.0%+/-1.9%), prescribing a medication not clinically preferred because clinically indicated or preferred medications were not covered or approved (29.4%+/-1.8%), and discontinuing medications as a result of prescription drug coverage or management issues (25.8%+/-1.6%). With patient case mix adjusted to control for sociodemographic and clinical confounders, patients with medication access problems had 3.6 times greater likelihood of adverse events (p<.001), including emergency visits, hospitalizations, homelessness, suicidal ideation or behavior, or incarceration. Also, all prescription drug management features were significantly associated with increased medication access problems and adverse events (p<.001). States with more access problems had significantly higher adverse event rates (p<.001). CONCLUSIONS These associations indicate that more effective Medicaid prescription drug management and financing practices are needed to promote medication continuity and improve treatment outcomes.
Collapse
Affiliation(s)
- Joyce C West
- American Psychiatric Institute for Research and Education Psychiatric Practice Research Network, American Psychiatric Association, 1000 Wilson Blvd., Arlington, VA 22209, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Duffy FF, Craig T, Moscicki EK, West JC, Fochtmann LJ. Performance in Practice: Clinical Tools to Improve the Care of Patients with Posttraumatic Stress Disorder. FOC 2009. [DOI: 10.1176/foc.7.2.foc186] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
21
|
Abstract
OBJECTIVES To describe factors associated with initiation of depot antipsychotic medications in psychiatric outpatients with schizophrenia and recent medication nonadherence. METHODS A national sample of psychiatrists reported on adult outpatients with schizophrenia who were nonadherent with oral antipsychotic medications in the last year. RESULTS In total, 17.6% of psychiatrists initiated depot antipsychotic injections. Initiation was significantly and positively associated with public insurance, prior inpatient admission, proportion of time nonadherent, average or above average intellectual functioning, and living in a mental health residence. Use was inversely associated with using second-generation antipsychotics and other oral psychotropic medications prior to medication nonadherence. Psychiatrists who were male, nonwhite, and more optimistic about managing nonadherence were more likely to initiate depot injections. CONCLUSIONS Initiation of depot injections is a joint function of patient, physician, treatment, and setting factors. Use of long-acting preparations in this population is uncommon despite clinical recommendations urging their use.
Collapse
Affiliation(s)
- Joyce C. West
- American Psychiatric Institute for Research and Education, 1000 Wilson Boulevard, Suite 1825, Arlington, VA
| | - Steven C. Marcus
- University of Pennsylvania School of Social Policy and Practice, Philadelphia, PA
| | - Joshua Wilk
- American Psychiatric Institute for Research and Education, 1000 Wilson Boulevard, Suite 1825, Arlington, VA
| | - Lisa M. Countis
- American Psychiatric Institute for Research and Education, 1000 Wilson Boulevard, Suite 1825, Arlington, VA
| | - Darrel A. Regier
- American Psychiatric Institute for Research and Education, 1000 Wilson Boulevard, Suite 1825, Arlington, VA
| | - Mark Olfson
- To whom correspondence should be addressed; New York State Psychiatric Institute/Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, New York, NY 10032; tel: 212-543-5293, fax: 212-568-3534, e-mail:
| |
Collapse
|
22
|
Abstract
OBJECTIVES This study examined psychiatrists' opinions regarding the use of second-generation antipsychotics for treatment-resistant schizophrenia. It then sought to identify factors associated with these opinions. METHODS A national survey was conducted (September 2003-January 2004) of psychiatrists engaged in the management of patients with schizophrenia. RESULTS Among survey respondents (N=431), most psychiatrists (88%) believed that one or more of the five currently available second-generation antipsychotics could improve treatment-resistant positive symptoms after a failed trial of optimal oral haloperidol treatment. Psychiatrists who reported familiarity with schizophrenia practice guidelines were more likely to have high levels of optimism that these medications improve positive symptoms (odds ratio [OR]=3.6, 95% confidence interval [CI]=1.4-9.3, p=.009). Psychiatrists who met with a pharmaceutical representative at least once a week were also more likely to have high levels of optimism toward second-generation antipsychotics (OR=2.3, CI=1.4-3.9, p=.001). CONCLUSIONS Reported familiarity with treatment guidelines and frequent contact with pharmaceutical representatives appear to be associated with optimism toward second-generation antipsychotics.
Collapse
Affiliation(s)
- Melissa R Arbuckle
- Department of Psychiatry, Columbia University, New York State Psychiatric Institute, New York, NY 10032, USA
| | | | | | | | | | | |
Collapse
|
23
|
Wilk JE, West JC, Rae DS, Rubio-Stipec M, Chen JJ, Regier DA. Medicare Part D prescription drug benefits and administrative burden in the care of dually eligible psychiatric patients. Psychiatr Serv 2008; 59:34-9. [PMID: 18182537 DOI: 10.1176/ps.2008.59.1.34] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE With implementation of Medicare Part D, concerns were raised that patients with severe mental illness who were dually eligible for both Medicaid and Medicare benefits would be at clinical risk. In addition to concerns about medication access and continuity, there were concerns about administrative burden for physicians and their staffs. This study aimed to quantify the amount of administrative burden for psychiatrists and their staff related to Medicare Part D prescription drug plan administration in a national sample of dually eligible psychiatric patients and to identify factors associated with increased burden. METHODS A total of 5,833 psychiatrists were randomly selected from the American Medical Association's Physicians Masterfile. Responses were obtained from 64% (N=3,247) with a mailed survey using practice-based survey research methods during the first four months of Medicare Part D implementation (January to April 2006); 1,183 psychiatrists met eligibility requirements. RESULTS Psychiatrists and their staff spent 45 minutes in administrative tasks for every one hour of direct patient care for dually eligible patients. Drug plan features, including prior authorization and preferred drug formularies, and medication access problems were associated with increased administrative time. CONCLUSIONS Results of this study indicate several drug plan features and medication access problems related to Part D implementation were associated with significant increases in administrative burden for psychiatrists and their staff, which may result in less time for direct patient care. Given the vulnerability of this high-risk population, this increased administrative burden may pose a significant risk to the overall quality of care for psychiatric patients.
Collapse
Affiliation(s)
- Joshua E Wilk
- American Psychiatric Institute for Research and Education, Arlington, VA 22209, USA.
| | | | | | | | | | | |
Collapse
|
24
|
Fochtmann LJ, Duffy FF, West JC, Kunkle R, Plovnick RM. Performance in Practice: Sample Tools for the Care of Patients with Major Depressive Disorder. FOC 2008. [DOI: 10.1176/foc.6.1.foc22] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
25
|
Kreyenbuhl J, Marcus SC, West JC, Wilk J, Olfson M. Adding or switching antipsychotic medications in treatment-refractory schizophrenia. Psychiatr Serv 2007. [PMID: 17602016 DOI: 10.1176/appi.ps.58.7.983] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE This study compared patients with schizophrenia whose antipsychotic medications were switched to manage treatment-resistant positive psychotic symptoms with those for whom another antipsychotic was added. Psychiatrists' characteristics and perceptions of effectiveness of the medication change on clinical outcomes were also reported. METHODS Psychiatrists participating in a nationally representative mailed survey (N=209) reported on the clinical features, management, and response to the change in antipsychotic medication (added versus switched) of one adult patient with treatment-refractory schizophrenia under their care for at least one year. RESULTS Thirty-three percent of patients were treated with an added antipsychotic medication. Compared with patients whose antipsychotic medications were switched, those with an added antipsychotic medication were more likely to be female, to have received care from the same psychiatrist for more than two years, and to have been recently prescribed an antidepressant. Compared with psychiatrists who switched antipsychotic prescriptions, those who added an antipsychotic reported that the change was less likely to reduce positive symptoms, improve functioning, and prevent hospitalization. Psychiatrists who added rather than switched antipsychotics reported more frequent attendance at educational programs sponsored by a pharmaceutical company. CONCLUSIONS Consistent with other lines of research and practice guideline recommendations, psychiatrists perceive antipsychotic polypharmacy to be a generally ineffective strategy for treatment-resistant positive psychotic symptoms. In light of these findings, efforts to identify and implement more effective evidence-based pharmacologic approaches should be undertaken.
Collapse
Affiliation(s)
- Julie Kreyenbuhl
- Department of Psychiatry, Division of Services Research, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
| | | | | | | | | |
Collapse
|
26
|
Abstract
OBJECTIVE This study compared patients with schizophrenia whose antipsychotic medications were switched to manage treatment-resistant positive psychotic symptoms with those for whom another antipsychotic was added. Psychiatrists' characteristics and perceptions of effectiveness of the medication change on clinical outcomes were also reported. METHODS Psychiatrists participating in a nationally representative mailed survey (N=209) reported on the clinical features, management, and response to the change in antipsychotic medication (added versus switched) of one adult patient with treatment-refractory schizophrenia under their care for at least one year. RESULTS Thirty-three percent of patients were treated with an added antipsychotic medication. Compared with patients whose antipsychotic medications were switched, those with an added antipsychotic medication were more likely to be female, to have received care from the same psychiatrist for more than two years, and to have been recently prescribed an antidepressant. Compared with psychiatrists who switched antipsychotic prescriptions, those who added an antipsychotic reported that the change was less likely to reduce positive symptoms, improve functioning, and prevent hospitalization. Psychiatrists who added rather than switched antipsychotics reported more frequent attendance at educational programs sponsored by a pharmaceutical company. CONCLUSIONS Consistent with other lines of research and practice guideline recommendations, psychiatrists perceive antipsychotic polypharmacy to be a generally ineffective strategy for treatment-resistant positive psychotic symptoms. In light of these findings, efforts to identify and implement more effective evidence-based pharmacologic approaches should be undertaken.
Collapse
Affiliation(s)
- Julie Kreyenbuhl
- Department of Psychiatry, Division of Services Research, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
| | | | | | | | | |
Collapse
|
27
|
Abstract
Public concerns about the perils associated with incomplete or delayed reporting of results from clinical trials has heightened interest in trial registries and results databases. Here we review the current status of trial registration efforts and the challenges in developing a comprehensive system of trial registration and reporting of results. ClinicalTrials.gov, the largest trial registry with 36 249 trials from approximately 140 countries, has procedures in place to help ensure that records are valid and informative. Key challenges include the need to minimize inadvertent duplicate registrations, to ensure that interventions have unambiguous names, and to have a search engine that identifies all trials that meet a user's specifications. Recent policy initiatives have called for the development of a database of trial results. Several issues confound the implementation of such a database, including the lack of an accepted format or process for providing summaries of trial results to the public and concerns about disseminating data in the absence of independent scientific review.
Collapse
Affiliation(s)
- Deborah A Zarin
- National Library of Medicine, National Institutes of Health, US Department of Health and Human Services, Bethesda, Md, USA.
| | | | | | | | | | | |
Collapse
|
28
|
West JC, Wilk JE, Muszynski IL, Rae DS, Rubio-Stipec M, Alter CL, Narrow WE, Regier DA. Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit. Am J Psychiatry 2007; 164:789-96. [PMID: 17475738 DOI: 10.1176/ajp.2007.164.5.789] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE This study attempted to systematically assess the experiences of Medicare and Medicaid "dual-eligible" psychiatric patients, including evaluating patients' access to medications and the administrative functioning of the program, during the first 4 months of the Medicare Part D prescription drug benefit. METHOD Psychiatrists (N=5,833) were randomly selected from the American Medical Association's Physicians Masterfile. After exclusion of those not practicing and with undeliverable addresses, 64% responded; 35% met study eligibility criteria of treating at least one dual-eligible patient during their last typical workweek and reported clinically detailed information on one systematically selected patient. RESULTS A total of 53.4% had at least one medication access problem to report between Jan. 1 and April 30, 2006. Although 9.7% experienced improved medication access, 22.3% discontinued or temporarily stopped taking medication because of prescription drug coverage or management issues, and 18.3% were previously stable but were required to switch medications. Among those with medication access problems, 27.3% experienced a significant adverse clinical event; 19.8% had an emergency room visit. Most drug plan features studied, including preferred drug/formulary lists, prior authorization, medication dosing/number limits, "fail-first" protocols, and requirements to switch to generics, were associated with significantly higher rates of medication access problems. CONCLUSIONS The findings indicate consequential medication access problems for psychiatric patients during the implementation of Medicare Part D. Although Centers for Medicare and Medicaid Services policies were enacted to ensure access to protected classes of psychopharmacologic medications, the high rates of medication access problems observed indicate further refinement of these policies is needed.
Collapse
Affiliation(s)
- Joyce C West
- American Psychiatric Institute for Research and Education, American Psychiatric Association, Practice Research Network, 1000 Wilson Blvd., Suite 1825, Arlington, VA 22209, USA.
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Wilk J, West JC, Rae DS, Regier DA. Relationship of comorbid substance and alcohol use disorders to disability among patients in routine psychiatric practice. Am J Addict 2007; 15:180-5. [PMID: 16595357 DOI: 10.1080/10550490500528799] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Abstract
The primary aim of this study was to present data on the relationship of mental and comorbid substance use disorders to work disability and functioning in routine psychiatric practice in the United States. Data were used from the 1997 and 1999 American Psychiatric Institute for Research and Education's Practice Research Network Study of Psychiatric Patients and Treatments, totaling 754 psychiatrists and 3,088 patients. Results found patients with comorbid substance use disorders had significantly higher rates of work disability. These findings highlight the critical need to address the disturbing lack of substance use treatment and rehabilitation services for this population.
Collapse
Affiliation(s)
- Joshua Wilk
- Practice Research Network, American Psychiatric Institute for Research and Education, Washington, DC, USA.
| | | | | | | |
Collapse
|
30
|
Regier DA, Bufk LF, Whitaker T, Duffy FF, Narrow WE, Rae DS, Reed GM, Rehman OF, Rubio-Stipec M, Weismiller T, Wilk JE, West JC. Parity And The Use Of Out-Of-Network Mental Health Benefits In The FEHB Program. Health Aff (Millwood) 2007; 27:w70-83. [DOI: 10.1377/hlthaff.27.1.w70] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Darrel A. Regier
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| | - Lynn F. Bufk
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| | - Tracy Whitaker
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| | - Farifteh F. Duffy
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| | - William E. Narrow
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| | - Donald S. Rae
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| | - Geoffrey M. Reed
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| | - Omar F. Rehman
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| | - Maritza Rubio-Stipec
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| | - Toby Weismiller
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| | - Joshua E. Wilk
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| | - Joyce C. West
- Darrel Regier is executive director of the American Psychiatric Institute for Research and Education (APIRE) in Arlington, Virginia. Lynn Bufka is assistant executive director, Practice Research and Policy, at the American Psychological Association in Washington, D.C. Tracy Whitaker is director of the Center for Workforce Studies, National Association of Social Workers (NASW), in Washington, D.C. Farifteh Duffy is a research scientist at APIRE; William Narrow is APIRE's associate director; and Donald
| |
Collapse
|
31
|
Wilk JE, West JC, Narrow WE, Marcus S, Rubio-Stipec M, Rae DS, Pincus HA, Regier DA. Comorbidity patterns in routine psychiatric practice: is there evidence of underdetection and underdiagnosis? Compr Psychiatry 2006; 47:258-64. [PMID: 16769299 DOI: 10.1016/j.comppsych.2005.08.007] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2005] [Revised: 06/07/2005] [Accepted: 08/31/2005] [Indexed: 11/22/2022] Open
Abstract
OBJECTIVE The purpose of this study is to present data on the rates of diagnosis and patterns of Axis I comorbidity treated by psychiatrists in routine psychiatric practice, ascertained by practicing psychiatrists, and compare them with those ascertained through structured interview in a national sample of individuals treated in the specialty mental health sector for evidence of underdetection or underdiagnosis of comorbid disorders in routine psychiatric practice. METHODS Data on 2117 psychiatric patients gathered by 754 psychiatrists participating in the 1997 and 1999 American Psychiatric Institute for Research and Education's Practice Research Network's Study of Psychiatric Patients and Treatments (SPPT) were analyzed, assessing psychiatrist-reported rates of Axis I disorders and comorbidities. SPPT data on patients treated by psychiatrists were compared with a clinical subset of patients in the National Comorbidity Survey who had been treated in the specialty mental health sector (SMA). RESULTS Rates of comorbidity were higher in the SMA (53.9%) than in the SPPT (31.5%). The prevalence of schizophrenia diagnoses was more than twice as prevalent in the SPPT as in the SMA sample; anxiety disorders were 2 to 22 times more prevalent in the SMA sample. In the SPPT, 4 of the 10 most prevalent comorbid pairs included schizophrenia or bipolar disorder; only one pair in the SMA sample included either diagnoses. Of the 10 most prevalent comorbidity pairings in the SMA sample, 6 included a phobia diagnosis. CONCLUSIONS Results of these analyses suggest greater differences in the patterns and rates of comorbidities than one might expect between these 2 samples. Possible reasons for these disparities, including methodological differences in diagnostic ascertainment and underdiagnosis of anxiety disorders, are discussed.
Collapse
Affiliation(s)
- Joshua E Wilk
- American Psychiatric Institute of Research and Education, Arlington, VA 22209, USA.
| | | | | | | | | | | | | | | |
Collapse
|
32
|
Abstract
This study utilized a large clinical dataset of patients representative of those in routine U.S. psychiatric practice to assess the influence of sociodemographic variables and diagnostic class on health plan membership (public or private). Data on patients with schizophrenia or other psychotic disorders (n=288) and patients with mood or anxiety disorders (n=1304) were obtained from a cross-sectional practice-based survey conducted by the American Psychiatric Institute for Research and Education. The likelihood of health plan membership was lower among males and among those from a minority race/ethnicity. Health plan membership was also affected by educational attainment and employment status. Even after controlling for these sociodemographic determinants of health plan membership, individuals with schizophrenia/other psychotic disorders were significantly less likely to belong to a health plan than those with mood/anxiety disorders.
Collapse
Affiliation(s)
- Michael T Compton
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
| | | | | | | | | |
Collapse
|
33
|
Abstract
OBJECTIVE Psychotherapy has long been recognized as a key component of psychiatric care. However, concerns have been raised about access to psychotherapy as a result of changes in the financing and management of care. This study examined patterns and predictors of receipt of psychotherapy among patients of psychiatrists. METHODS Data were collected for 587 psychiatrists who participated in the American Psychiatric Institute for Research and Education's Practice Research Network 1999 Study of Psychiatric Patients and Treatments, which generated nationally representative data for 1,589 adult patients. RESULTS Findings indicate that more than 66 percent of patients of psychiatrists received some form of psychotherapy from the psychiatrist or another provider in the past 30 days--56 percent from their psychiatrist and 10 percent from another clinician. Although 72 percent of patients with depression received psychotherapy, more than half of those with schizophrenia did not. CONCLUSIONS A majority of patients of psychiatrists received psychotherapy from their psychiatrist. However, these rates varied by demographic, diagnostic, and health plan characteristics and by practice setting. Further research determining if these observed patterns of psychotherapy are related to differential outcomes is needed.
Collapse
Affiliation(s)
- Joshua E Wilk
- American Psychiatric Institute for Research and Education's Practice Research Network, 1000 Wilson Boulevard, Suite 1825, Arlington, Virginia 22209, USA.
| | | | | | | |
Collapse
|
34
|
Herbeck DM, Fitek DJ, Svikis DS, Montoya ID, Marcus SC, West JC. Treatment compliance in patients with comorbid psychiatric and substance use disorders. Am J Addict 2006; 14:195-207. [PMID: 16019970 PMCID: PMC2599916 DOI: 10.1080/10550490590949488] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
Abstract
This study examines clinical and non-clinical factors associated with treatment compliance problems in 342 patients with substance use disorders (SUD) seen in routine psychiatric practice. Weighted Wald-X(2) and multivariate logistic regression assessed sociodemographic, clinical, treatment, and health plan characteristics associated with treatment compliance problems. Among patients with SUD, 40.5% were reported to currently have treatment compliance problems. Patients with treatment compliance problems were significantly more likely to have personality disorders, lower global assessment of functioning scores, and medication side effects than those without treatment compliance problems. Patients seen by psychiatrists who were reimbursed by discounted rather than undiscounted fee-for-service were five times more likely to be reported to have treatment compliance problems. Both clinical and non-clinical factors appear to be associated with treatment compliance problems. Understanding these factors and targeting treatment interventions may improve treatment compliance and patient outcomes.
Collapse
Affiliation(s)
- Diane M Herbeck
- University of California-Los Angeles Integrated Substance Abuse Programs, Los Angeles, CA 90025, USA.
| | | | | | | | | | | |
Collapse
|
35
|
Abstract
OBJECTIVE The purpose of this study was to assess the effects of patients' awareness of their illness on the clinical presentation, management, and course of nonadherence to antipsychotic medications among patients with schizophrenia. METHODS A national survey was conducted of psychiatrists who were treating patients with schizophrenia. The survey was sent to 771 psychiatrists, of whom 534 responded, for a response rate of 69 percent. The psychiatrists were asked to report on presentation, management, and course for one adult patient with schizophrenia who had been under their care for at least one year and who had been nonadherent to oral antipsychotics at some point in the past year. Patients who were aware that they had a mental illness were compared with those who were not aware. RESULTS Of the 534 respondent psychiatrists, 310 reported on an eligible patient, and 300 of these patients were classified by illness awareness. Ninety-seven patients, or 32 percent, were not aware that they had a mental illness. These patients who lacked awareness had significantly longer episodes of antipsychotic nonadherence, were more likely to completely cease taking the antipsychotic medication, were more likely to have severe positive symptoms, and were more likely to be psychiatrically hospitalized after nonadherence than those who were aware of their illness. Psychological interventions and several types of family interventions were significantly less effective among patients who lacked awareness. CONCLUSIONS A lack of awareness of mental illness is common among patients with schizophrenia who are nonadherent to antipsychotics. Such nonadherence tends to be especially disruptive and unresponsive to simple commonly used psychological interventions.
Collapse
Affiliation(s)
- Mark Olfson
- Department of Psychiatry, Columbia University, New York State Psychiatric Institute, 1051 Riverside Drive, New York, New York 10032, USA.
| | | | | | | |
Collapse
|
36
|
Compton MT, West JC, Olfson M. Prolonged duration of untreated psychosis in nonaffective first-episode psychotic disorders compared to other psychoses. Int J Psychiatry Clin Pract 2006; 10:264-8. [PMID: 24941145 DOI: 10.1080/13651500600736684] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Introduction. While the consequences of the duration of untreated psychosis (DUP) represent an active area of research, less attention has been focused on the determinants of the DUP. This analysis assessed several potential determinants of the DUP from a practice-based survey. Method. Data on selected patients in their first treatment episode for psychotic symptoms were obtained from 104 practicing physicians. Patients with a long DUP (n=31), defined as >4 weeks, were compared to patients with a short DUP (≤4 weeks, n=28). Results. The long-DUP group had a higher percentage of patients with nonaffective psychotic disorders (58%) compared to the short-DUP group (29%). The median DUP among those with nonaffective psychotic disorders was 8 weeks, compared to 3 weeks among those with other psychotic disorders. The long-DUP group had a higher percentage of patients rated as uncertain about or denying a mental illness (55% compared to 25% in the short-DUP group). The presence of negative symptoms approached significance in terms of differentiating between the two groups, with 66% of the long-DUP group having negative symptoms compared to 39% of the short-DUP group. When three variables (nonaffective psychotic disorder versus other psychoses, insight, and negative symptoms) were entered into a logistic regression model, only diagnostic category remained an independently significant predictor. Conclusion. In this practice-based sample, patients with nonaffective psychotic disorders were more likely to have a longer DUP than patients who developed psychotic symptoms in the context of mood disorders, substance use disorders, or other disorders.
Collapse
Affiliation(s)
- Michael T Compton
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, , Atlanta, GA, USA
| | | | | |
Collapse
|
37
|
West JC, Herbeck DM, Bell CC, Colquitt WL, Duffy FF, Fitek DJ, Rae D, Stipec MR, Snowden L, Zarin DA, Narrow WE. Race/Ethnicity Among Psychiatric Patients: Variations in Diagnostic and Clinical Characteristics Reported by Practicing Clinicians. FOC 2006. [DOI: 10.1176/foc.4.1.48] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
38
|
Compton MT, Weiss PS, West JC, Kaslow NJ. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems. Soc Psychiatry Psychiatr Epidemiol 2005; 40:939-46. [PMID: 16247563 DOI: 10.1007/s00127-005-0964-4] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/09/2005] [Indexed: 11/30/2022]
Abstract
BACKGROUND Substance abuse among individuals with schizophrenia-spectrum disorders (SSDs) is associated with a range of adverse psychosocial outcomes in the areas of occupational functioning, housing stability, economic independence, access to health care, and involvement with the legal system. The aim of this study was to estimate the effects of substance use disorders (SUDs), SSDS, and dual diagnosis with both disorders on the risk for six important Axis IV psychosocial problems. This was accomplished using a large dataset of patients who are representative of individuals in routine US psychiatric practice. METHOD Weighted data from the 1999 Study of Psychiatric Patients and Treatments from a practice-based research network of the American Psychiatric Institute for Research and Education were analyzed. Some 615 US psychiatrists provided detailed clinical, psychosocial, and health services information on 1,843 patients, including 285 patients with one or more SUDs without an SSD, 180 patients with a diagnosis of an SSD without substance abuse comorbidity, and 68 dually diagnosed patients. Logistic regression models were used to determine effect estimates (adjusted odds ratios), and corresponding 95% confidence intervals were calculated. RESULTS After adjusting for sociodemographic variables and for SSD diagnosis, SUD diagnosis was independently associated with increased risk for five of the Axis IV psychosocial problems of interest (occupational problems, housing problems, economic problems, problems with access to health care services, and problems related to interaction with the legal system/crime) when compared to all other psychiatric patients (n=1,310). After adjusting for the sociodemographic variables and for SUD diagnosis, SSD diagnosis (compared to all other psychiatric diagnoses) was associated with Axis IV economic problems, but not with the other five psychosocial problems of interest. The presence of both an SUD and an SSD diagnosis (dual diagnosis) was associated with a greater risk for four of the six Axis IV psychosocial problems studied, compared to the risks associated with either diagnosis alone. Limiting the substance of abuse to alcohol resulted in similar findings. CONCLUSIONS Although SUDs are associated with increased risk for poor social adjustment, the comorbidity of SUDs and SSDs is associated with greatly compounded psychosocial burdens. These findings, from a large sample of representative US psychiatric patients, demonstrate the ongoing need for improved services and policies for those specially burdened patients with the dual diagnosis of both an SSD and substance abuse or dependence.
Collapse
Affiliation(s)
- Michael T Compton
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
| | | | | | | |
Collapse
|
39
|
Compton MT, Rudisch BE, Weiss PS, West JC, Kaslow NJ. Predictors of psychiatrist-reported treatment-compliance problems among patients in routine U.S. psychiatric care. Psychiatry Res 2005; 137:29-36. [PMID: 16223527 DOI: 10.1016/j.psychres.2005.07.009] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/10/2004] [Revised: 06/17/2005] [Accepted: 07/15/2005] [Indexed: 11/21/2022]
Abstract
Characteristics associated with psychiatrist-reported treatment-compliance problems were investigated using the 1999 Study of Psychiatric Patients and Treatments from the Practice Research Network of the American Psychiatric Institute for Research and Education (n=1,843). Logistic regression was used to study characteristics associated with compliance problems as perceived by treating psychiatrists. Among the 22 potential predictors of interest, all but three (age, gender, and problems with primary support group) were found to be significantly associated with treatment-compliance problems in bivariate analyses. A predictive model was developed consisting of eight independently significant predictors from diagnostic, clinical, psychosocial, and treatment-history domains. These predictors included substance use disorder diagnosis, medication side effects, moderate to severe psychotic symptoms, personality disorder diagnosis, economic problems, prior hospitalization, current Global Assessment of Functioning scale score, and duration of treatment with current psychiatrist. This predictive model correctly identified the presence or absence of treatment-compliance problems in 91% of patients in a sample randomly drawn from the dataset before model construction. These findings may be useful to clinicians, researchers, and program planners interested in addressing the important issue of treatment-compliance problems in psychiatric care settings.
Collapse
Affiliation(s)
- Michael T Compton
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Suite 4000, Atlanta, GA 30322, USA.
| | | | | | | | | |
Collapse
|
40
|
Colenda CC, Wilk JE, West JC. The geriatric psychiatry workforce in 2002: analysis from the 2002 National Survey of Psychiatric Practice. Am J Geriatr Psychiatry 2005; 13:756-65. [PMID: 16166404 DOI: 10.1176/appi.ajgp.13.9.756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
OBJECTIVE Using the 2002 National Survey of Psychiatric Practice (NSPP), authors update demographic and professional work activities of a nationally representative sample of the psychiatric workforce who treat geriatric patients. METHODS The sampling frame for the 2002 NSPP used the American Medical Association's Masterfile of Physicians. Professional, demographic, and patient data are compared between general and self-reported geriatric psychiatrists. Authors also present detailed analyses comparing high geriatric providers (HGPs; geriatric caseloads >20%), and board-certified geriatric psychiatrists (BCGPs). RESULTS The proportion of HGPs in the 2002 NSPP was 26.0% of all respondents and was 28.1% among American Psychiatric Association (APA)-member respondents. Among the APA-member psychiatrists, this reflected a 55% increase from the 1996 NSPP. Of HGPs, 31.0% were certified in geriatric psychiatry. As compared with general psychiatrists, proportionally fewer men and American medical-school graduates were self-reported geriatric psychiatrists. Geriatric psychiatrists saw nearly three times as many geriatric patients and five times as many dementia patients as did their generalist counterparts. Mood-disorder patients were the largest treatment group, however. Investigators observed no significant differences in professional and practice characteristics between HGPs and BCGPs. CONCLUSIONS About 1 in 4 psychiatrists in the 2002 survey are HGPs. Geriatric psychiatrists treat proportionally more geriatric patients than do generalists, but they do not have exclusively geriatric practices. The similarities between HGPs and BCGPs raise issues about the incentives for geriatric psychiatry certification, but not the need to train subspecialists to serve as faculty and community resources.
Collapse
Affiliation(s)
- Christopher C Colenda
- College of Medicine, 147 Joe H. Reynolds Medical Bldg., Texas A&M University System Health Science Center, College Station, TX 77845-1114, USA.
| | | | | |
Collapse
|
41
|
Affiliation(s)
- Joshua E Wilk
- American Psychiatric Institute for Research and Education's Practice Research Network, 1000 Wilson Boulevard, Suite 1825, Arlington, Virginia 22209, USA.
| | | | | | | | | |
Collapse
|
42
|
West JC, Wilk JE, Olfson M, Rae DS, Marcus S, Narrow WE, Pincus HA, Regier DA. Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice. Psychiatr Serv 2005; 56:283-91. [PMID: 15746502 DOI: 10.1176/appi.ps.56.3.283] [Citation(s) in RCA: 76] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVES This study provided generalizable national data on the treatment of adult patients with schizophrenia in the United States and assessed conformance with the practice guideline treatment recommendations of the Schizophrenia Patient Outcomes Research Team and the American Psychiatric Association. METHODS National data from the American Psychiatric Institute for Research and Education's 1999 Practice Research Network study of psychiatric patients and treatments were used to examine treatment patterns for 151 adult patients with schizophrenia. Analyses were performed and adjusted for the weights and sample design to generate nationally representative estimates. RESULTS Findings indicated that patients with schizophrenia who were treated by psychiatrists had complex clinical problems and were markedly disabled. Forty-one percent of patients had a comorbid axis I disorder, and 75 percent were currently unemployed. Thirty-five percent were currently experiencing medication side effects, and 37 percent were currently experiencing problems with treatment adherence. Although most patients received guideline-consistent psychopharmacologic treatment, treatment was characterized by significant polypharmacy. Rates of conformance with the guideline recommendations were significantly lower for psychosocial recommendations than for psychopharmacologic recommendations. Although 69 percent of patients received at least some psychosocial treatment, none of the unemployed patients received vocational rehabilitation services in the past 30 days. CONCLUSIONS These data suggest unmet need for psychosocial treatment services among individuals with schizophrenia. These findings raise questions about whether currently available antipsychotic medications are being used optimally or whether they offer limited effectiveness for patients with complex clinical problems who are treated in routine psychiatric practice.
Collapse
Affiliation(s)
- Joyce C West
- American Psychiatric Institute for Research and Education's Practice Research Network, Arlington, Virginia 22209, USA.
| | | | | | | | | | | | | | | |
Collapse
|
43
|
Duffy FF, Narrow WE, Rae DS, West JC, Zarin DA, Rubio-Stipec M, Pincus HA, Regier DA. Concomitant pharmacotherapy among youths treated in routine psychiatric practice. J Child Adolesc Psychopharmacol 2005; 15:12-25. [PMID: 15741782 DOI: 10.1089/cap.2005.15.12] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVES The aim of this study was to assess rates and correlates of concomitant pharmacotherapy in children and adolescents treated by psychiatrists in a broad range of clinical settings. METHODS Cross-sectional data on 392 child and adolescent patients aged 2-17 years from the 1997 and 1999 American Psychiatric Practice Research Network Study of Psychiatric Patients and Treatments were used, and weighted estimates are provided. RESULTS Findings indicate that 84% of child and adolescent patients received one or more psychopharmacologic medications; 52% of patients treated with medications received concomitant pharmacotherapy (i.e., two or more medications). Patients who were treated with psychopharmacologic treatments received a median of 2 medications (range, 1-6). Highest rates of concomitant pharmacotherapy were among patients with bipolar disorder (87%). Correlates of concomitant pharmacotherapy included: (1) having a diagnosis of bipolar disorder, (2) having co-occurring Axis I or II disorders or general medical conditions, and (3) currently receiving treatment in an inpatient setting. CONCLUSIONS Over 40% of child and adolescent patients of psychiatrists were prescribed two or more psychopharmacologic medications. Patients with chronic and clinically complex conditions were more likely to receive concomitant pharmacotherapy. Most often, efficacy of U.S. Food and Drug Administration (FDA)-approved medications has been examined as monotherapy, and cautions on drug interactions and off-label use derived from multiple sources accompany each product. With high rates of concomitant pharmacotherapy among children and adolescents in psychiatric care, additional research on efficacy and safety of this treatment strategy is necessary.
Collapse
|
44
|
Zarin DA, Young JL, West JC. Challenges to evidence-based medicine: a comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network. Soc Psychiatry Psychiatr Epidemiol 2005; 40:27-35. [PMID: 15624072 DOI: 10.1007/s00127-005-0838-9] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/01/2004] [Indexed: 10/26/2022]
Abstract
BACKGROUND The practice of evidence-based medicine depends on the availability of clinically relevant research, yet questions have been raised about the generalizability of findings from randomized controlled trials (RCTs). OBJECTIVES The aim of this study was to quantify differences between RCT patients and treatments and those in day-to-day clinical practice. RESEARCH DESIGN Data from published reports of two key RCTs underlying recent treatment advances in psychiatry were compared with data on routine psychiatric practice collected through a Practice Research Network (PRN). SETTING Hospital inpatient units (RCT) and the full range of psychiatric practice settings in the United States (PRN). SUBJECTS Adults with bipolar I disorder and adults with schizophrenia. MEASURES Demographic (age, gender, race), clinical (principal diagnoses, comorbid conditions, psychosocial functioning, and histories of hospitalization), and treatment (medication name and dosage) characteristics. RESULTS PRN patients had more comorbid conditions and were more likely to be white, female, and older than RCT patients. In all, 38% of PRN patients with schizophrenia and 55% of PRN patients with bipolar I disorder would have been ineligible for the corresponding RCT. Most PRN patients receiving an RCT study medication were also receiving other medications not allowed by the RCT protocol. CONCLUSIONS Findings support the assertion that RCT patients and treatments are not typical of those in clinical practice, and most patients in clinical practice are receiving treatments that do not have direct empirical support. Research is needed to determine the extent to which RCT findings should be used to guide routine clinical decisions.
Collapse
Affiliation(s)
- Deborah A Zarin
- Technology Assessment Program Agency for Healthcare Research and Quality (AHRQ), Rockville, MD, USA
| | | | | |
Collapse
|
45
|
Duffy FF, Narrow W, West JC, Fochtmann LJ, Kahn DA, Suppes T, Oldham JM, McIntyre JS, Manderscheid RW, Sirovatka P, Regier D. Quality of care measures for the treatment of bipolar disorder. Psychiatr Q 2005; 76:213-30. [PMID: 16080418 DOI: 10.1007/s11126-005-2975-4] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The staff of the American Psychiatric Association (APA), the American Psychiatric Institute for Research and Education (APIRE), and a national panel of experts in bipolar disorder and practice guideline development have collaborated to generate a set of quality of care indicators for the pharmacologic and psychosocial treatment of bipolar disorder. The indicators were derived from APA's evidence-based Practice Guideline for the Treatment of Patients with Bipolar Disorder, 2002 (1) and the Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder, 2000 (2) These quality indicators can be used for quality monitoring, benchmarking, and quality improvement efforts across health plans, systems of care, and health care providers to improve quality and outcomes of care for patients with bipolar disorder.
Collapse
Affiliation(s)
- Farifteh Firoozmand Duffy
- American Psychiatric Institute for Research and Education, 1000 Wilson Blvd, Suite 1825, Arlington, Virginia 22209, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
West JC, Kosten TR, Wilk J, Svikis D, Triffleman E, Rae DS, Narrow WE, Duffy FF, Regier DA. Challenges in increasing access to buprenorphine treatment for opiate addiction. Am J Addict 2004; 13 Suppl 1:S8-16. [PMID: 15204672 DOI: 10.1080/10550490490440753] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Abstract
The aims of this study are to assess psychiatrists' comfort using office-based opiate agonist treatment (OBOT) and to identify psychiatrist characteristics associated with OBOT comfort. A random sample of 2,323 AMA Masterfile of Physicians psychiatrists were surveyed through the 2002 APIRE National Survey of Psychiatric Practice (NSSP). Of the 52% responding (N = 1,203), 80.6% (SE = 1.8%) were not comfortable providing OBOT. Males, addiction-certified psychiatrists, and those treating substance abuse patients were more comfortable providing OBOT. These findings highlight significant barriers in providing buprenorphine treatment. Increasing the understanding of specific financing and services delivery barriers that clinicians face is needed to inform the development of effective integrated services models and policies to facilitate OBOT implementation.
Collapse
Affiliation(s)
- Joyce C West
- Psychiatric Research Network, American Psychiatric Institute for Research and Education, 1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Herbeck DM, West JC, Ruditis I, Duffy FF, Fitek DJ, Bell CC, Snowden LR. Variations in use of second-generation antipsychotic medication by race among adult psychiatric patients. Psychiatr Serv 2004; 55:677-84. [PMID: 15175466 DOI: 10.1176/appi.ps.55.6.677] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE This study examined variations in the use of second-generation antipsychotic medication among African-American and non-Hispanic white patients in a national sample of adults who were treated by psychiatrists. METHODS This study used data from studies of psychiatric patients and treatments that were conducted by the American Psychiatric Institute for Research and Education's (APIRE's) Practice Research Network (PRN). Psychiatrists provided detailed clinical data for 126 African-American patients and 574 white patients who were randomly selected and for whom antipsychotic medications were prescribed. The study assessed differences by race in the use of second-generation antipsychotic medication, adjusting for clinical, sociodemographic, and health-system characteristics, including patients' source of payment for treatment. RESULTS African-American patients were less likely than white patients to receive second-generation antipsychotic medications (49 percent compared with 66 percent). After the analysis statistically adjusted for clinical, sociodemographic, and health-system characteristics, African-American patients remained less likely than white patients to receive second-generation antipsychotics. CONCLUSIONS Because African Americans tended to receive medications that are not first-line recommended treatments and that have a greater risk of producing tardive dyskinesia and extrapyramidal side effects, African Americans could be expected to suffer diminished clinical status. This disparity may also contribute to lower rates of adherence and to more frequent emergency department visits and psychiatric hospitalizations among African Americans
Collapse
|
48
|
Abstract
OBJECTIVE This study examined the relationship between utilization management techniques and psychiatrists' treatment plan modifications. METHOD Nationally representative data on 1,843 patients treated by 615 psychiatrists participating in the American Psychiatric Institute for Research and Education's Practice Research Network were used to examine the demographic and clinical characteristics of patients whose care was subjected to utilization management and to assess the association between utilization management and psychiatrists' treatment plan modifications. RESULTS Approximately half of all patients had treatment that was subject to utilization management (52.6%). For the patients whose treatment was not subject to utilization management, 15.5% had their treatment plan changed compared to the 31.5% who were subject to utilization management. Overall, after adjustment for differences in patients, settings, and psychiatrist characteristics, the patients subject to utilization management were 2.6 times more likely to have their treatment changed than the patients who were not subject to utilization management. These patients were 3.7 times more likely to have their type of treatment changed and 2.3 times more likely to have their frequency or number of visits changed. Psychiatrists in individual practice settings and those with nonsalaried income sources were more likely to modify treatment decisions for their patients when subject to utilization management. CONCLUSIONS The presence of utilization management is highly associated with changes in psychiatrists' treatment decisions. When compared to evidence-based treatment recommendations, these changes seem likely to result in less than optimal care.
Collapse
Affiliation(s)
- Devra C Mintz
- Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Miami, FL 33101, USA
| | | | | | | | | |
Collapse
|
49
|
Affiliation(s)
- Joyce C West
- American Psychiatric Institute for Research and Education's (APIRE's) Practice Research Network, Arlington, Virginia 22209, USA.
| | | | | | | | | |
Collapse
|
50
|
|